Session Schedule

Find a specific presentation in the session by navigating to the timestamp indicated below.

0:00:00
Introduction

0:00:30
Medical aspects of oral appliance therapy in a randomized, controlled, non-inferiority trial of patients with OSA and health morbidities in Asia
Yihui Ou (Singapore)

0:26:15
Considerations in oral appliance design for different populations in the management of sleep-disordered breathing
Simona Orlej (Czech Republic)

0:48:55
Phenotyping patients with sleep-disordered breathing disorders for management with oral appliances
May-Nak Lau (Malaysia)

1:08:40
British airways – Medical effects and dental outcomes of oral appliances in Caucasians with sleep-disordered breathing
Lindsay Winchester (United Kingdom)

1:30:30
Question and answer

Summary

The global prevalence and burden of sleep-disordered breathing are high. More than a billion adults worldwide are estimated to have sleep-disordered breathing (SDB). Populations from different ethnic groups or ancestries have variable prevalence from multifactorial and complex pathoaetiologies. One in three and up to half in community groups have moderate to severe OSA. Hypertension and OSA are common bed-partners, the latter being an underlying cause of between 25 to 50 percent of secondary hypertension. The gold standard management of SDB is continuous positive airway pressure (CPAP) therapy but long-term adherence is poor with consequential medical multi-comorbidities and increased resource utilisation. The results of research studies will be presented to strengthen the rigour of evidence for oral appliance with better design for improved adherence as an alternative to CPAP therapy in the management of cardiac health outcomes in patients with SDB. Research data inform evidence-based recommendations in a non-interventional approach by practitioners and healthcare policymakers in managing populations with SDB and health morbidities.